<div id="readability-page-1"><p>Ninety One UK Ltd raised its holdings in shares of  Zoetis Inc. (NYSE:ZTS - Free Report) by 19.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor  owned 1,119,132 shares of the company's stock after buying an additional 183,686 shares during the period. Ninety One UK Ltd owned about 0.25% of Zoetis worth $163,751,000 as of its most recent SEC filing.</p><ul><li>Which Pet Stock Should Get Your Tail Wagging in 2024?</li></ul><p>Several other hedge funds have also recently added to or reduced their stakes in ZTS. IAM Advisory LLC lifted its holdings in shares of  Zoetis by 3.2% during the third quarter. IAM Advisory LLC now owns 10,694 shares of the company's stock valued at $1,565,000 after purchasing an additional 332 shares during the last quarter.  Allspring Global Investments Holdings LLC increased its stake in  Zoetis by 0.9% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 96,442 shares of the company's stock worth $14,172,000 after purchasing an additional 828 shares in the last quarter.  Security National Bank raised its holdings in  Zoetis by 4.8% during the 3rd quarter. Security National Bank now owns 53,870 shares of the company's stock worth $7,882,000 after buying an additional 2,445 shares during the period.  Legal Advantage Investments Inc. raised its holdings in  Zoetis by 29.8% during the 3rd quarter. Legal Advantage Investments Inc. now owns 8,500 shares of the company's stock worth $1,244,000 after buying an additional 1,950 shares during the period.  Finally, YANKCOM Partnership lifted its stake in  Zoetis by 7.2% during the third quarter. YANKCOM Partnership now owns 2,321 shares of the company's stock valued at $340,000 after buying an additional 156 shares in the last quarter. Institutional investors and hedge funds own  92.80% of the company's stock. </p><h2>Analyst Ratings Changes</h2><p>Several research firms have recently weighed in on ZTS. Morgan Stanley  set a $160.00 target price on shares of Zoetis in a research report on Thursday, December 18th. Barclays began coverage on Zoetis in a report on Monday, December 8th. They issued an &#34;equal weight&#34; rating and a $136.00 target price for the company. BTIG Research  reaffirmed a &#34;buy&#34; rating and issued a $160.00 target price on shares of Zoetis in a research report on Wednesday, December 3rd. Argus  reissued a &#34;buy&#34; rating and set a $190.00 price target on shares of Zoetis in a research report on Tuesday, September 9th. Finally, Bank of America lowered Zoetis from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and set a $135.00 price objective for the company. in a research report on Monday, December 15th. Six analysts have rated the stock with a Buy rating, seven have assigned  a Hold rating and one  has assigned  a Sell rating to the company's stock. According to data from MarketBeat, the stock  has an average rating of &#34;Hold&#34; and an average price target of $160.18.</p><ul><li>MarketBeat Week in Review – 07/31 - 08/04</li></ul><p><b>Read Our Latest Stock Report on Zoetis</b></p><h2>Zoetis Price Performance</h2><p>ZTS opened at $125.82 on Thursday. The stock has a fifty day moving average price of $125.84 and a 200 day moving average price of $142.13. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.40. The stock has a market cap of $55.45 billion, a price-to-earnings ratio of 21.18, a PEG ratio of 2.75 and a beta of 0.97. </p><ul><li>Rising Dividend Make Zoetis a Doggone Winner</li></ul><p>Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.08. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The business's revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS.  Analysts forecast that  Zoetis Inc. will post 6.07 EPS for the current fiscal year. </p><h2>Zoetis Increases Dividend</h2><p>The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. This is a positive change from Zoetis's previous quarterly dividend of $0.50. The ex-dividend date is Tuesday, January 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. Zoetis's dividend payout ratio (DPR) is currently 33.67%. </p><h2>Zoetis Profile</h2> (Free Report)<p>Zoetis Inc <span>NYSE: ZTS<span></span></span> is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.  </p><p>Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Zoetis</li><li>The Best $1 You'll Spend This Holiday Season</li><li>Holiday surprise: $1 gets you everything</li><li>America’s “most deplorable” Christmas sale</li><li>Do not delete, read immediately</li><li>Market Panic: Trump Just Dropped a Bomb on Your Stocks</li></ul><p><strong>Want to see what other hedge funds are holding ZTS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Zoetis Right Now?</h2><p>Before you consider Zoetis, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.</p><p>While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Ninety One UK Ltd increased its holdings in Zoetis Inc. (NYSE:ZTS) by 19.6% in Q3, owning 1,119,132 shares valued at $163.75 million. Other institutional investors also adjusted their stakes. Analysts have mixed ratings on Zoetis, with an average target price of $160.18. The stock opened at $125.82, with a market cap of $55.45 billion. Zoetis reported Q3 earnings of $1.70 per share, exceeding estimates, and announced a dividend increase to $0.53 per share, payable on March 3rd.</p>

Zoetis Inc. $ZTS Stock Holdings Increased by Ninety One UK Ltd